Peoplein (PPE) H2 2024 earnings summary

Executive summary

• Revenue remained stable at AUD 1.17 billion (down 1% year-over-year), with market share gains in key segments despite challenging economic conditions.

• Normalized EBITDA fell 39.5% to AUD 37 million, mainly due to lower permanent recruitment revenue and a shift to lower-margin sectors.

• Cost reduction initiatives, including a 10% headcount cut, delivered AUD 7.8 million in ongoing savings and improved operational efficiency.

• Leadership structure reset and brand consolidation established a client-centric growth platform, especially in health and aged care.

• Dividend paused to preserve balance sheet strength and agility for future opportunities.

Financial highlights

• Net revenue reached AUD 156.2 million, down 16.6% year-over-year; underlying NPATA dropped 41% to AUD 22.2 million.

• Underlying EBIT decreased 62.4% to AUD 16.6 million; normalized EBITDA margin contracted to 3.1% from 5.1% in FY23.

• Total billed hours fell 2.3% to 21.5 million, but Q4 saw a 4% sequential increase and outperformed peers.

• Cash conversion in H2 was strong at 105% of EBITDA; debtor days steady at 31.

• NPATA per share was 21.2 cents, down from 37.0 cents.

Outlook and guidance

• Trading conditions expected to remain tough for at least the next six months, with no immediate signs of business confidence recovery.

• Positioned for growth when the economy turns, with ongoing transformation and efficiency initiatives.

• Strong pipeline of new contract wins in Q4 FY24 anticipated to drive growth in FY25.

• Program UNITE to complete in H1 FY25, with further efficiency gains expected.

• Forecast reduction in net debt for FY25, with lower capex and tax payments.